Newron Pharmaceuticals
NWRN.SW
#8289
Rank
ยฃ0.13 B
Marketcap
ยฃ7.23
Share price
-2.15%
Change (1 day)
83.24%
Change (1 year)

Revenue for Newron Pharmaceuticals (NWRN.SW)

Revenue in 2023: ยฃ7.88 Million

According to Newron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ7.88 Million. In 2023 the company made a revenue of ยฃ7.88 Million an increase over the revenue in the year 2022 that were of ยฃ5.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Newron Pharmaceuticals from 2005 to 2023

Annual revenue

Year Revenue Change
2023ยฃ7.88 M53.16%
2022ยฃ5.14 M0.17%
2021ยฃ5.13 M0.9%
2020ยฃ5.09 M-17.97%
2019ยฃ6.2 M71.22%
2018ยฃ3.62 M-71.42%
2017ยฃ12.68 M218.38%
2016ยฃ3.98 M94.46%
2015ยฃ2.04 M37.42%
2014ยฃ1.49 M-61.25%
2013ยฃ3.84 M-58.6%
2012ยฃ9.29 M111.93%
2011ยฃ4.38 M568.93%
2010ยฃ0.65 M-77.14%
2009ยฃ2.86 M-33.76%
2008ยฃ4.32 M-8.02%
2007ยฃ4.7 M280.38%
2006ยฃ1.23 M
2005N/A